
Sign up to save your podcasts
Or


This seminar describes the lessons learned from a deep-dive workshop about how to adapt to the Inflation Reduction Act's measures to control drug prices in the US, but it is equally relevant for any pharma or medtech company trying to influence market access or reimbursement policy.
By Professor Brian D SmithThis seminar describes the lessons learned from a deep-dive workshop about how to adapt to the Inflation Reduction Act's measures to control drug prices in the US, but it is equally relevant for any pharma or medtech company trying to influence market access or reimbursement policy.

26,405 Listeners